Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Tremfya (guselkumab) for the Treatment of Plaque Psoriasis

Drug (Brand / Generic)

Tremfya / guselkumab

Developer

Janssen Biotech

Therapy Class

Human monoclonal antibody

Product Description

Selective interleukin (IL)-23 inhibitor

Current Indication

Plaque psoriasis

Market Sector

Dermatology

Development Status

Approved in the US
Expand

Go Top